tert-Butyl (S)-2-(5-(4'-(2-((S)-1-(tert-butoxycarbonyl)pyrrolidin-2-yl)-1H-imidazol-5-yl)-[1,1'-biphenyl]-4-yl)oxazol-2-yl)pyrrolidine-1-carboxylate
| Product Name |
tert-Butyl (S)-2-(5-(4'-(2-((S)-1-(tert-butoxycarbonyl)pyrrolidin-2-yl)-1H-imidazol-5-yl)-[1,1'-biphenyl]-4-yl)oxazol-2-yl)pyrrolidine-1-carboxylate
|
| Product Code |
DA-D005-01
|
| Chemical name |
tert-Butyl (S)-2-(5-(4'-(2-((S)-1-(tert-butoxycarbonyl)pyrrolidin-2-yl)-1H-imidazol-5-yl)-[1,1'-biphenyl]-4-yl)oxazol-2-yl)pyrrolidine-1-carboxylate
|
| Synonyms |
NA
|
| Impurity |
NA
|
| CAS Number |
NA
|
| Alternate CAS # |
NA
|
| Molecular form |
C36H43N5O5
|
| Appearance |
NA
|
| Melting Point |
NA
|
| Mol. Weight |
625.77
|
| Storage |
2-8°C Refrigerator
|
| Solubility |
NA
|
| Stability |
NA
|
| Category |
pharmaceutical standards,intermediates,Fine Chemicals
|
| Boiling Point |
NA
|
| Applications |
It is an impurity of Daclatasvir. Daclatasvir, inhibits the HCV protein NS5A, and thus can be used as a drug candidate for the treatment of hepatitis C (HCV).
|
| Dangerous Goods Info |
NA
|
| References |
NA
|
| Extra Notes |
NA
|
| Documents (MSDS) |
No Data Available
|
| Keywords |
NA |
